Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: The PRECEDENT study

This publication has 19 references indexed in Scilit:

• Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure
  New England Journal of Medicine, 2000
• Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: Insights from the Flolan International Randomized Survival Trial (FIRST)
  American Heart Journal, 1999
• Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: A randomized, double-blind, placebo-controlled clinical trial
  Published by Elsevier ,1999
• Torsade de Pointes Ventricular Tachycardia During Low Dose Intermittent Dobutamine Treatment in a Patient with Dilated Cardiomyopathy and Congestive Heart Failure
  Pacing and Clinical Electrophysiology, 1999
• Hemodynamic and Renal Excretory Effects of Human Brain Natriuretic Peptide Infusion in Patients With Congestive Heart Failure
  Circulation, 1996
• Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
  Circulation, 1994
• Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
  New England Journal of Medicine, 1991
• Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure.
  Circulation, 1991
• Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure
  American Heart Journal, 1986
• Arrhythmias Associated with Intermittent Outpatient Dobutamine Infusion
  Angiology, 1986